Skip to main content
OpenTrials
Completed

NCT Number: NCT01226862

Advancing Telestroke Care: A Prospective Observational Study

This study will promote the development and economic sustainability of telemedicine for acute stroke treatment.

Completed

Looking for future studies?

Notify Me

Key information

Conditions

Stroke Brain Diseases Cardiovascular Diseases Central Nervous System Diseases Cerebrovascular Disorders Nervous System Diseases Vascular Diseases

Age range

18 year and older

Sex eligibility

All sexes

Study type

Observational

Primary location

University of Southern California

Los Angeles, California, 90033, United States

About this study

The goal of this study is to promote the development and economic sustainability of telemedicine for acute stroke treatment. The study's objectives are 1) to determine if the use of telemedicine consultations for stroke patients will improve their care per guidelines compared to stroke patients treated by control hospitals; and 2) to determine if the care per guidelines provided via telemedicine consultations for stroke patients will be similar or equivalent to care per guidelines provided to stroke patients treated at hub hospitals.

The Advancing Telestroke Care study will establish treatment and outcomes in three distinct study cohorts: hub telemedicine hospital, spoke telemedicine hospital and non-telemedicine control hospital.

Who can participate

Healthy volunteers accepted: No

Only the study team can determine whether someone qualifies for participation.

Inclusion criteria

  • Age greater than or equal to 18 years old
  • Acute ischemic stroke within 12 hours of stroke onset

Exclusion criteria

  • Life expectancy less than 90 days
  • Patient unwilling to participate in study

Treatment and study plan

Primary outcomes

  1. IV tPA administration

    Time frame: Day 7/Discharge

    Correctness of decisions regarding IV tPA administration in acute stroke

Secondary outcomes

  1. Multiple Study Assessments

    Time frame: Day 7 and/or Day 30 and/or Day 90 and/or at discharge

    There are 23 assessments, after stroke, for outcome measures. They include: hospital transfers, treatment with reperfusions therapies, treatment with antiplatelets, hypertension treatment, hyperglycemia treatment, hyperlipidemia treatment, symptomatic ICH, mortality, imaging/diagnostic data, stroke and rehab scale scores, number of hospitalizations since last assessment, hospital LOS, discharge location, number of physician visits, and work status.

Sponsors and collaborators

Lead sponsor

National Stroke Association, United States

Other

Collaborators

  • California Pacific Medical Center
  • Mayo Clinic
  • Swedish Medical Center
  • University of Southern California
  • University of Utah

Registry information

Acronym: ATC

Important dates

Study start
2010
Primary completion
2013
Study completion
2013
First posted
Oct 22, 2010
Registry last updated
Dec 5, 2013

OpenTrials presents study information sourced from ClinicalTrials.gov. The official registry record should be consulted for the latest information.

View the official ClinicalTrials.gov record (opens in a new tab)

This listing is for discovery and informational purposes only. It is not medical advice, does not guarantee that a study is recruiting, and does not determine eligibility. Contact the study team and a qualified healthcare professional when considering participation.

Related clinical trials

Published trials that share one or more normalized conditions with this study.